世界・日本のランセット市場2022-2028

【英語タイトル】Global and Japan Lancets Market Report Forecast 2022-2028

QYResearchが出版した調査資料(HNI893KU421)・商品コード:HNI893KU421
・発行会社(調査会社):QYResearch
・発行日:2022年3月
・ページ数:約130
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,350 ⇒換算¥661,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,525 ⇒換算¥991,800見積依頼/購入/質問フォーム
Enterprise License(法人閲覧用)USD8,700 ⇒換算¥1,322,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

This report focuses on global and Japan Lancets market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Lancets market size is estimated to be worth US$ xx million in 2022 and is forecast to a readjusted size of US$ xx million by 2028 with a CAGR of xx% during the review period. Fully considering the economic change by this health crisis, by Type, XX accounting for xx% of the Lancets global market in 2021, is projected to value US$ xx million by 2028, growing at a revised xx% CAGR in the post-COVID-19 period. While by Application, XX was the leading segment, accounting for over XX percent market share in 2021, and altered to an xx % CAGR throughout this forecast period.
In Japan the Lancets market size is expected to grow from US$ XX million in 2021 to US$ XX million by 2028, at a CAGR of XX% during the forecast period.
Lancets market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global Lancets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
For Japan market, this report focuses on the Lancets market size by players, by Type, and by Application, for the period 2017-2028. The key players include the global and local players which play important roles in Japan.

Segment by Type
 Safety Lancets
 Ordinary Lancets

Segment by Application
 Cholesterol Tests
 Glucose Tests
 Others

By Region
 North America
 U.S.
 Canada
 Asia-Pacific
 China
 Japan
 South Korea
 India
 Australia
 Europe
 Germany
 France
 U.K.
 Italy
 Russia
 Latin America
 Mexico
 Brazil
 Argentina
 Middle East & Africa
 Turkey
 Saudi Arabia
 UAE

By Company
 Roche
 Lifescan
 BD
 Ascensia
 Abbott
 B. Braun
 ARKRAY
 Terumo
 I-SENS
 Nipro
 Omron
 AgaMatrix
 Smiths Medical
 Sarstedt
 SINOCARE
 Yicheng
 Yuwell
 Greiner Bio One

❖ レポートの目次 ❖

1 Study Coverage
1.1 Lancets Product Introduction
1.2 Global Lancets Outlook 2017 VS 2022 VS 2028
1.2.1 Global Lancets Sales in US$ Million for the Year 2017-2028
1.2.2 Global Lancets Sales in Volume for the Year 2017-2028
1.3 Japan Lancets Outlook 2017 VS 2022 VS 2028
1.3.1 Japan Lancets Sales in US$ Million for the Year 2017-2028
1.3.2 Japan Lancets Sales in Volume for the Year 2017-2028
1.4 Lancets Market Size, Japan VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of Japan Lancets in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Lancets Market Size, Japan VS Global, 2017 VS 2022 VS 2028
1.5 Lancets Market Dynamics
1.5.1 Lancets Industry Trends
1.5.2 Lancets Market Drivers
1.5.3 Lancets Market Challenges
1.5.4 Lancets Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Lancets by Type
2.1 Lancets Market Segment by Type
2.1.1 Safety Lancets
2.1.2 Ordinary Lancets
2.2 Global Lancets Market Size by Type
2.2.1 Global Lancets Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Lancets Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Lancets Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 Japan Lancets Market Size by Type
2.3.1 Japan Lancets Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 Japan Lancets Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 Japan Lancets Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Lancets by Application
3.1 Lancets Market Segment by Application
3.1.1 Cholesterol Tests
3.1.2 Glucose Tests
3.1.3 Others
3.2 Global Lancets Market Size by Application
3.2.1 Global Lancets Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Lancets Sales in Volume, by Application (2017, 2022 & 2028)
3.2.3 Global Lancets Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 Japan Lancets Market Size by Application
3.3.1 Japan Lancets Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 Japan Lancets Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Japan Lancets Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Lancets Competitor Landscape by Company
4.1 Global Lancets Market Size by Company
4.1.1 Top Global Lancets Manufacturers Ranked by Revenue (2021)
4.1.2 Global Lancets Revenue by Manufacturer (2017-2022)
4.1.3 Global Lancets Sales by Manufacturer (2017-2022)
4.1.4 Global Lancets Price by Manufacturer (2017-2022)
4.2 Global Lancets Concentration Ratio (CR)
4.2.1 Lancets Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Lancets in 2021
4.2.3 Global Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Lancets Manufacturing Base Distribution, Product Type
4.3.1 Global Lancets Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Lancets Product Type
4.3.3 Date of International Manufacturers Enter into Lancets Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 Japan Lancets Market Size by Company
4.5.1 Top Lancets Players in Japan, Ranked by Revenue (2021)
4.5.2 Japan Lancets Revenue by Players (2020, 2021 & 2022)
4.5.3 Japan Lancets Sales by Players (2020, 2021 & 2022)
5 Global Lancets Market Size by Region
5.1 Global Lancets Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Lancets Market Size in Volume by Region (2017-2028)
5.2.1 Global Lancets Sales in Volume by Region: 2017-2022
5.2.2 Global Lancets Sales in Volume Forecast by Region (2023-2028)
5.3 Global Lancets Market Size in Value by Region (2017-2028)
5.3.1 Global Lancets Sales in Value by Region: 2017-2022
5.3.2 Global Lancets Sales in Value by Region: 2023-2028
6 Segment in Regional Level & Country Level
6.1 North America
6.1.1 North America Lancets Market Size YoY Growth 2017-2028
6.1.2 North America Lancets Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Lancets Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Lancets Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.3 Europe
6.3.1 Europe Lancets Market Size YoY Growth 2017-2028
6.3.2 Europe Lancets Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Lancets Market Size YoY Growth 2017-2028
6.4.2 Latin America Lancets Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Lancets Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Lancets Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Roche
7.1.1 Roche Corporation Information
7.1.2 Roche Description and Business Overview
7.1.3 Roche Lancets Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Roche Lancets Products Offered
7.1.5 Roche Recent Development
7.2 Lifescan
7.2.1 Lifescan Corporation Information
7.2.2 Lifescan Description and Business Overview
7.2.3 Lifescan Lancets Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Lifescan Lancets Products Offered
7.2.5 Lifescan Recent Development
7.3 BD
7.3.1 BD Corporation Information
7.3.2 BD Description and Business Overview
7.3.3 BD Lancets Sales, Revenue and Gross Margin (2017-2022)
7.3.4 BD Lancets Products Offered
7.3.5 BD Recent Development
7.4 Ascensia
7.4.1 Ascensia Corporation Information
7.4.2 Ascensia Description and Business Overview
7.4.3 Ascensia Lancets Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Ascensia Lancets Products Offered
7.4.5 Ascensia Recent Development
7.5 Abbott
7.5.1 Abbott Corporation Information
7.5.2 Abbott Description and Business Overview
7.5.3 Abbott Lancets Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Abbott Lancets Products Offered
7.5.5 Abbott Recent Development
7.6 B. Braun
7.6.1 B. Braun Corporation Information
7.6.2 B. Braun Description and Business Overview
7.6.3 B. Braun Lancets Sales, Revenue and Gross Margin (2017-2022)
7.6.4 B. Braun Lancets Products Offered
7.6.5 B. Braun Recent Development
7.7 ARKRAY
7.7.1 ARKRAY Corporation Information
7.7.2 ARKRAY Description and Business Overview
7.7.3 ARKRAY Lancets Sales, Revenue and Gross Margin (2017-2022)
7.7.4 ARKRAY Lancets Products Offered
7.7.5 ARKRAY Recent Development
7.8 Terumo
7.8.1 Terumo Corporation Information
7.8.2 Terumo Description and Business Overview
7.8.3 Terumo Lancets Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Terumo Lancets Products Offered
7.8.5 Terumo Recent Development
7.9 I-SENS
7.9.1 I-SENS Corporation Information
7.9.2 I-SENS Description and Business Overview
7.9.3 I-SENS Lancets Sales, Revenue and Gross Margin (2017-2022)
7.9.4 I-SENS Lancets Products Offered
7.9.5 I-SENS Recent Development
7.10 Nipro
7.10.1 Nipro Corporation Information
7.10.2 Nipro Description and Business Overview
7.10.3 Nipro Lancets Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Nipro Lancets Products Offered
7.10.5 Nipro Recent Development
7.11 Omron
7.11.1 Omron Corporation Information
7.11.2 Omron Description and Business Overview
7.11.3 Omron Lancets Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Omron Lancets Products Offered
7.11.5 Omron Recent Development
7.12 AgaMatrix
7.12.1 AgaMatrix Corporation Information
7.12.2 AgaMatrix Description and Business Overview
7.12.3 AgaMatrix Lancets Sales, Revenue and Gross Margin (2017-2022)
7.12.4 AgaMatrix Lancets Products Offered
7.12.5 AgaMatrix Recent Development
7.13 Smiths Medical
7.13.1 Smiths Medical Corporation Information
7.13.2 Smiths Medical Description and Business Overview
7.13.3 Smiths Medical Lancets Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Smiths Medical Lancets Products Offered
7.13.5 Smiths Medical Recent Development
7.14 Sarstedt
7.14.1 Sarstedt Corporation Information
7.14.2 Sarstedt Description and Business Overview
7.14.3 Sarstedt Lancets Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Sarstedt Lancets Products Offered
7.14.5 Sarstedt Recent Development
7.15 SINOCARE
7.15.1 SINOCARE Corporation Information
7.15.2 SINOCARE Description and Business Overview
7.15.3 SINOCARE Lancets Sales, Revenue and Gross Margin (2017-2022)
7.15.4 SINOCARE Lancets Products Offered
7.15.5 SINOCARE Recent Development
7.16 Yicheng
7.16.1 Yicheng Corporation Information
7.16.2 Yicheng Description and Business Overview
7.16.3 Yicheng Lancets Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Yicheng Lancets Products Offered
7.16.5 Yicheng Recent Development
7.17 Yuwell
7.17.1 Yuwell Corporation Information
7.17.2 Yuwell Description and Business Overview
7.17.3 Yuwell Lancets Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Yuwell Lancets Products Offered
7.17.5 Yuwell Recent Development
7.18 Greiner Bio One
7.18.1 Greiner Bio One Corporation Information
7.18.2 Greiner Bio One Description and Business Overview
7.18.3 Greiner Bio One Lancets Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Greiner Bio One Lancets Products Offered
7.18.5 Greiner Bio One Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Lancets Industry Chain Analysis
8.2 Lancets Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Lancets Production Mode & Process
8.4 Lancets Sales and Marketing
8.4.1 Lancets Sales Channels
8.4.2 Lancets Distributors
8.5 Lancets Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

LIST OF TABLES
Table 1. Lancets CAGR in Value, Japan VS Global, 2017 VS 2022 VS 2028
Table 2. Lancets Market Trends
Table 3. Lancets Market Drivers
Table 4. Lancets Market Challenges
Table 5. Lancets Market Restraints
Table 6. Global Lancets Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. Japan Lancets Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Lancets Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. Japan Lancets Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Lancets Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Lancets Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Lancets Revenue Share by Manufacturer, 2017-2022
Table 13. Global Lancets Sales by Manufacturer, (M Units), 2017-2022
Table 14. Global Lancets Sales Share by Manufacturer, 2017-2022
Table 15. Global Lancets Price by Manufacturer (2017-2022) & (US$/K Units)
Table 16. Global Lancets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Lancets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lancets as of 2021)
Table 18. Top Players of Lancets in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Lancets Product Type
Table 20. Date of International Manufacturers Enter into Lancets Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Lancets Players in Japan Market, Ranking by Revenue (2021)
Table 23. Japan Lancets Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. Japan Lancets Revenue Share by Players, 2020, 2021 & 2022
Table 25. Japan Lancets Sales by Players, (M Units), 2020, 2021 & 2022
Table 26. Japan Lancets Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Lancets Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Lancets Sales in Volume by Region (2017-2022) & (M Units)
Table 29. Global Lancets Sales in Volume Forecast by Region (2023-2028) & (M Units)
Table 30. Global Lancets Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Lancets Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Lancets Sales in Volume by Country (2017-2028) & (M Units)
Table 33. North America Lancets Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia-Pacific Lancets Sales in Volume by Region (2017-2028) & (M Units)
Table 35. Asia-Pacific Lancets Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Lancets Sales in Volume by Country (2017-2028) & (M Units)
Table 37. Europe Lancets Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Lancets Sales in Volume by Country (2017-2028) & (M Units)
Table 39. Latin America Lancets Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Lancets Sales in Volume by Country (2017-2028) & (M Units)
Table 41. Middle East and Africa Lancets Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Roche Corporation Information
Table 43. Roche Description and Business Overview
Table 44. Roche Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 45. Roche Lancets Product
Table 46. Roche Recent Development
Table 47. Lifescan Corporation Information
Table 48. Lifescan Description and Business Overview
Table 49. Lifescan Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 50. Lifescan Lancets Product
Table 51. Lifescan Recent Development
Table 52. BD Corporation Information
Table 53. BD Description and Business Overview
Table 54. BD Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 55. BD Lancets Product
Table 56. BD Recent Development
Table 57. Ascensia Corporation Information
Table 58. Ascensia Description and Business Overview
Table 59. Ascensia Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 60. Ascensia Lancets Product
Table 61. Ascensia Recent Development
Table 62. Abbott Corporation Information
Table 63. Abbott Description and Business Overview
Table 64. Abbott Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 65. Abbott Lancets Product
Table 66. Abbott Recent Development
Table 67. B. Braun Corporation Information
Table 68. B. Braun Description and Business Overview
Table 69. B. Braun Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 70. B. Braun Lancets Product
Table 71. B. Braun Recent Development
Table 72. ARKRAY Corporation Information
Table 73. ARKRAY Description and Business Overview
Table 74. ARKRAY Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 75. ARKRAY Lancets Product
Table 76. ARKRAY Recent Development
Table 77. Terumo Corporation Information
Table 78. Terumo Description and Business Overview
Table 79. Terumo Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 80. Terumo Lancets Product
Table 81. Terumo Recent Development
Table 82. I-SENS Corporation Information
Table 83. I-SENS Description and Business Overview
Table 84. I-SENS Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 85. I-SENS Lancets Product
Table 86. I-SENS Recent Development
Table 87. Nipro Corporation Information
Table 88. Nipro Description and Business Overview
Table 89. Nipro Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 90. Nipro Lancets Product
Table 91. Nipro Recent Development
Table 92. Omron Corporation Information
Table 93. Omron Description and Business Overview
Table 94. Omron Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 95. Omron Lancets Product
Table 96. Omron Recent Development
Table 97. AgaMatrix Corporation Information
Table 98. AgaMatrix Description and Business Overview
Table 99. AgaMatrix Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 100. AgaMatrix Lancets Product
Table 101. AgaMatrix Recent Development
Table 102. Smiths Medical Corporation Information
Table 103. Smiths Medical Description and Business Overview
Table 104. Smiths Medical Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 105. Smiths Medical Lancets Product
Table 106. Smiths Medical Recent Development
Table 107. Sarstedt Corporation Information
Table 108. Sarstedt Description and Business Overview
Table 109. Sarstedt Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 110. Sarstedt Lancets Product
Table 111. Sarstedt Recent Development
Table 112. SINOCARE Corporation Information
Table 113. SINOCARE Description and Business Overview
Table 114. SINOCARE Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 115. SINOCARE Lancets Product
Table 116. SINOCARE Recent Development
Table 117. Yicheng Corporation Information
Table 118. Yicheng Description and Business Overview
Table 119. Yicheng Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 120. Yicheng Lancets Product
Table 121. Yicheng Recent Development
Table 122. Yuwell Corporation Information
Table 123. Yuwell Description and Business Overview
Table 124. Yuwell Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 125. Yuwell Lancets Product
Table 126. Yuwell Recent Development
Table 127. Greiner Bio One Corporation Information
Table 128. Greiner Bio One Description and Business Overview
Table 129. Greiner Bio One Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 130. Greiner Bio One Lancets Product
Table 131. Greiner Bio One Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Lancets Distributors List
Table 135. Lancets Customers List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources



★調査レポート[世界・日本のランセット市場2022-2028] (コード:HNI893KU421)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界・日本のランセット市場2022-2028]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆